| Name | Title | Contact Details |
|---|---|---|
Mark Lee |
Chief Legal Officer | Profile |
Ryan Delaney |
Head Of Legal | Profile |
Cellerant Therapeutics is a clinical stage biotechnology company focused on developing human stem cell and antibody therapies for oncology applications and blood-related disorders. Cellerant`s programs include: CLT-008, an off-the-shelf cellular immunotherapy, under evaluation in a multicenter, open-label, randomized, controlled Phase 2 clinical trial in patients with de novo AML; CSC030-ADC, a preclinical monoclonal antibody drug conjugate that selectively targets and kills leukemic stem and blast cells responsible for initiating and maintaining disease; and CSC012, a preclinical monoclonal antibody targeting leukemic and pre-leukemic stem cells for acute leukemias and myelodysplastic syndromes. The Company is also developing next generation CAR product candidates leveraging its proprietary immunocellular therapy and antibody discovery and development platform.
We are proud of our status as a Federally Qualified Healthcare Center (FQHC) and Patient- Centered Medical Home (PCMH), and of our history of providing comprehensive, quality, and affordable healthcare since 2009.
Northeastern Executive Group is a Cranberry Twp, PA-based company in the Business Services sector.
Vici Marketing Group is a Clearwater, FL-based company in the Business Services sector.
Webasto develops highly efficient quality products for motor vehicle use. You will find information about the company and its systems for installation as original equipment here.